Xiaolu Yiguan, a China-based medical consultancy startup backed by media company International Data Group, has secured RMB100m ($14.5m) in series B funding, China Money Network has reported.
Venture capital firms Redpoint Ventures and Sinovation Ventures co-led the round, which followed an undisclosed eight-figure renminbi sum from IDG Capital, the International Data Group VC affiliate that recently bought the company outright, and Morningside Ventures.
Xiaolu Yiguan provides online consultancy for patients suffering from chronic diseases or general poor health, providing treatments that rely on traditional Chinese medical methods such as herbal blends or diet-based solutions.
The company also sells traditional medicines, offers post-treatment monitoring and services, and provides health management for large businesses.
The funding will be used to expand Xiaolu Yiguan’s network of physicians and to strengthen its range of medical treatments and its logistics capabilities.